ZA894721B - Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor - Google Patents

Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor

Info

Publication number
ZA894721B
ZA894721B ZA894721A ZA894721A ZA894721B ZA 894721 B ZA894721 B ZA 894721B ZA 894721 A ZA894721 A ZA 894721A ZA 894721 A ZA894721 A ZA 894721A ZA 894721 B ZA894721 B ZA 894721B
Authority
ZA
South Africa
Prior art keywords
polypeptides
post
leader sequence
bacteria
translational modification
Prior art date
Application number
ZA894721A
Other languages
English (en)
Inventor
J Norman Hansen
Norman Hansen J
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of ZA894721B publication Critical patent/ZA894721B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA894721A 1988-07-05 1989-06-21 Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor ZA894721B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/214,959 US5218101A (en) 1988-07-05 1988-07-05 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor

Publications (1)

Publication Number Publication Date
ZA894721B true ZA894721B (en) 1990-03-28

Family

ID=22801074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894721A ZA894721B (en) 1988-07-05 1989-06-21 Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor

Country Status (14)

Country Link
US (1) US5218101A (no)
EP (1) EP0423224B1 (no)
JP (2) JP3326172B2 (no)
KR (1) KR0137961B1 (no)
AT (1) ATE175417T1 (no)
AU (1) AU640110B2 (no)
CA (1) CA1339414C (no)
DE (2) DE68928899T4 (no)
DK (1) DK191D0 (no)
IL (1) IL90832A (no)
NO (1) NO309200B1 (no)
NZ (1) NZ229538A (no)
WO (1) WO1990000558A1 (no)
ZA (1) ZA894721B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
US5348881A (en) * 1990-03-13 1994-09-20 Quest International Flavors & Good Ingredients Company, Division Of Indopco, Inc. Multiple bacteriocin producing lactococcus and compositions
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.
DK0579730T3 (da) * 1991-04-11 2003-03-31 Stichting Nl I Voor Zuivelonde Nisin A-lignende lantibiotika, mælkesyrebakterie der producerer sådanne lantibiotika, fremgangsmåde til konstruktion af sådanne mælkesyrebakterier og fremgangsmåde til konservering . . .
US5861376A (en) * 1991-07-01 1999-01-19 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Synthetically derived peptide
GB9207267D0 (en) * 1992-04-02 1992-05-13 Agricultural & Food Res Nisins
DE69433357T2 (de) * 1994-09-12 2004-09-09 Aventis Pharma Deutschland Gmbh Rekombinantes Mersacidin und Verfahren zu seiner Herstellung
US5919695A (en) * 1997-04-22 1999-07-06 Quest International, B.V. Method and culture for inhibiting undesired microorganisms with culture of Bacillus subtilis
AU8484798A (en) * 1997-07-18 1999-02-10 University Of Maryland Sublancin lantibiotic produced by (bacillus subtilis) 168
US6953683B2 (en) * 1997-07-18 2005-10-11 University Of Maryland Compositions and methods of inhibiting bacterial spore germination
CA2356955A1 (en) * 1998-12-24 2000-07-06 University Of Maryland Stable subtilin and methods of manufacture
US6759205B2 (en) 2000-06-29 2004-07-06 University Of Maryland Construction of a strain of Bacillus subtilis 168 that displays the sublancin lantibiotic on the surface of the cell
US7033766B2 (en) * 2000-06-29 2006-04-25 University Of Maryland Office Of Technology Commercialization Construction and screening of lantibody display libraries
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
WO2003063887A1 (en) * 2002-01-14 2003-08-07 University Of Maryland, College Park Compositions and method of inhibiting bacterial spore germination
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
DE602005009738D1 (de) 2004-12-07 2008-10-23 Applied Nanosystems Bv Verfahren zur herstellung und sekretion modifizierter peptide
EP1989219A1 (en) * 2006-02-13 2008-11-12 Boehringer Ingelheim Vetmedica Gmbh Method for the manufacture of lantibiotics
US7879973B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7923533B2 (en) * 2006-06-29 2011-04-12 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7910695B2 (en) * 2006-06-29 2011-03-22 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7879975B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716115A (en) * 1983-09-06 1987-12-29 Microlife Technics, Inc. Derived nisin producing microorganisms, method of production and use and products obtained thereby

Also Published As

Publication number Publication date
NO905638L (no) 1990-12-28
WO1990000558A1 (en) 1990-01-25
DE68928899T4 (de) 1999-11-25
EP0423224A4 (en) 1991-11-06
DK191A (da) 1991-01-02
DK191D0 (da) 1991-01-02
JP2002191383A (ja) 2002-07-09
KR0137961B1 (ko) 1998-04-30
CA1339414C (en) 1997-09-02
NO309200B1 (no) 2000-12-27
JP3418388B2 (ja) 2003-06-23
EP0423224A1 (en) 1991-04-24
NO905638D0 (no) 1990-12-28
ATE175417T1 (de) 1999-01-15
US5218101A (en) 1993-06-08
KR900701819A (ko) 1990-12-04
IL90832A0 (en) 1990-01-18
AU3968489A (en) 1990-02-05
JPH03505670A (ja) 1991-12-12
IL90832A (en) 1995-06-29
AU640110B2 (en) 1993-08-19
NZ229538A (en) 1992-01-29
DE68928899T2 (de) 1999-08-12
JP3326172B2 (ja) 2002-09-17
DE68928899D1 (de) 1999-02-18
EP0423224B1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
ZA894721B (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor
GR3021708T3 (en) Human vascular permeability factor
GR3027722T3 (en) Osteogenic devices
GB8718777D0 (en) Variants of bovine pancreatic trypsin inhibitor
AU629649B2 (en) Novel procoagulant proteins
IL88293A0 (en) Alveolar surfactant proteins
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
ATE110775T1 (de) Verfahren zur herstellung von hirudin.
DE3876240D1 (no)
AU3327789A (en) Expression of the hiv 24 kda 24 gag protein in methylotrophic yeast
NO893572D0 (no) Lunge-overflateaktivt protein og beslektet polypeptid.